Novartis Opens New Radioligand Therapy Facility in California
I'm PortAI, I can summarize articles.
Novartis AG has opened a new 10,000-square-foot radioligand therapy manufacturing facility in Carlsbad, California, marking its third RLT site in the US. This expansion is part of a $23 billion investment in US infrastructure over five years, which includes new facilities in Florida and Texas, and expansions in North Carolina, Indiana, and New Jersey. Additionally, Novartis plans to establish a biomedical research innovation hub in San Diego, emphasizing its commitment to enhancing cancer care and strengthening US operations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments